Rank | Gene Set | Z-score |
---|---|---|
1 | hemidesmosome assembly (GO:0031581) | 9.24785898 |
2 | desmosome organization (GO:0002934) | 4.67147194 |
3 | maturation of 5.8S rRNA (GO:0000460) | 4.59847529 |
4 | keratinocyte proliferation (GO:0043616) | 4.40392100 |
5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32119962 |
6 | negative regulation of cell killing (GO:0031342) | 3.90132380 |
7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.90132380 |
8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.84871470 |
9 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.59874429 |
10 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.58350603 |
11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.56276831 |
12 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.40329878 |
13 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.40095844 |
14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.33825172 |
15 | establishment of skin barrier (GO:0061436) | 3.17709012 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16476898 |
17 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06476154 |
18 | cell-substrate junction assembly (GO:0007044) | 2.97166951 |
19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.96776967 |
20 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.92572117 |
21 | regulation of water loss via skin (GO:0033561) | 2.91235130 |
22 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.89085093 |
23 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.86807095 |
24 | hair cycle (GO:0042633) | 2.86687315 |
25 | molting cycle (GO:0042303) | 2.86687315 |
26 | keratinocyte development (GO:0003334) | 2.83636958 |
27 | cellular response to interleukin-15 (GO:0071350) | 2.83415155 |
28 | T-helper 1 type immune response (GO:0042088) | 2.80530791 |
29 | positive regulation of epidermis development (GO:0045684) | 2.80379319 |
30 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.73672988 |
31 | tolerance induction (GO:0002507) | 2.71785070 |
32 | response to interleukin-15 (GO:0070672) | 2.69532514 |
33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67881287 |
34 | type I interferon signaling pathway (GO:0060337) | 2.66257474 |
35 | cellular response to type I interferon (GO:0071357) | 2.66257474 |
36 | positive regulation of B cell differentiation (GO:0045579) | 2.65770516 |
37 | negative T cell selection (GO:0043383) | 2.64675960 |
38 | DNA deamination (GO:0045006) | 2.63650352 |
39 | response to type I interferon (GO:0034340) | 2.63204110 |
40 | regulation of hair follicle development (GO:0051797) | 2.61400182 |
41 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.61385388 |
42 | nuclear pore complex assembly (GO:0051292) | 2.61295155 |
43 | regulation of hypersensitivity (GO:0002883) | 2.60784705 |
44 | negative thymic T cell selection (GO:0045060) | 2.58207755 |
45 | positive regulation of hair follicle development (GO:0051798) | 2.56285170 |
46 | positive regulation of hair cycle (GO:0042635) | 2.56285170 |
47 | rRNA methylation (GO:0031167) | 2.53542392 |
48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.53106627 |
49 | leukocyte aggregation (GO:0070486) | 2.52461514 |
50 | positive regulation of isotype switching (GO:0045830) | 2.52361834 |
51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52022247 |
52 | macrophage activation involved in immune response (GO:0002281) | 2.51861512 |
53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.50773581 |
54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.49975839 |
55 | immunoglobulin mediated immune response (GO:0016064) | 2.49827052 |
56 | regulation of translational termination (GO:0006449) | 2.48282813 |
57 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.47378140 |
58 | modulation by symbiont of host immune response (GO:0052553) | 2.46585841 |
59 | positive regulation by symbiont of host defense response (GO:0052509) | 2.46585841 |
60 | modulation by symbiont of host defense response (GO:0052031) | 2.46585841 |
61 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.46585841 |
62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.46585841 |
63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.46585841 |
64 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.45571015 |
65 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.45268597 |
66 | B cell mediated immunity (GO:0019724) | 2.43955990 |
67 | ribosome assembly (GO:0042255) | 2.43440309 |
68 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.42787597 |
69 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.42026648 |
70 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.41588799 |
71 | regulation of gamma-delta T cell activation (GO:0046643) | 2.41462359 |
72 | interferon-gamma secretion (GO:0072643) | 2.39844813 |
73 | keratinization (GO:0031424) | 2.39475549 |
74 | negative regulation of B cell proliferation (GO:0030889) | 2.39024290 |
75 | negative regulation of protein oligomerization (GO:0032460) | 2.34819267 |
76 | detection of bacterium (GO:0016045) | 2.34225178 |
77 | regulation of regulatory T cell differentiation (GO:0045589) | 2.33936797 |
78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.33378502 |
79 | pore complex assembly (GO:0046931) | 2.32517843 |
80 | nucleotide transmembrane transport (GO:1901679) | 2.31965088 |
81 | necroptotic process (GO:0070266) | 2.31529405 |
82 | neutrophil activation involved in immune response (GO:0002283) | 2.31214430 |
83 | detection of other organism (GO:0098543) | 2.28874907 |
84 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.28194895 |
85 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.28033634 |
86 | positive regulation of T cell mediated immunity (GO:0002711) | 2.27396792 |
87 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.26105312 |
88 | rRNA modification (GO:0000154) | 2.26092828 |
89 | regulation of T cell mediated immunity (GO:0002709) | 2.24293588 |
90 | regulation of B cell differentiation (GO:0045577) | 2.24236246 |
91 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.23797137 |
92 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.23020352 |
93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.21073574 |
94 | positive regulation of interferon-beta production (GO:0032728) | 2.18521228 |
95 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.18296773 |
96 | negative regulation of ligase activity (GO:0051352) | 2.18296773 |
97 | nuclear pore organization (GO:0006999) | 2.16659369 |
98 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.15921121 |
99 | thymic T cell selection (GO:0045061) | 2.15632531 |
100 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.14525392 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.94171987 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.46822817 |
3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.93334888 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.77969827 |
5 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.66637250 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.57851530 |
7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.53343947 |
8 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.33267860 |
9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.32429356 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.30440742 |
11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.30204127 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29694790 |
13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.12350160 |
14 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.11063090 |
15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02462489 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01709573 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94821084 |
18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.94742602 |
19 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.92664410 |
20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89363205 |
21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.85653093 |
22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82926172 |
23 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.78225928 |
24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.77590234 |
25 | MYB_26560356_Chip-Seq_TH2_Human | 1.76888387 |
26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.73765042 |
27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72680699 |
28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72269550 |
29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.67489828 |
30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.66985932 |
31 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.65846687 |
32 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.65846687 |
33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65702574 |
34 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.63109048 |
35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62383011 |
36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62218360 |
37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.60247168 |
38 | MYB_26560356_Chip-Seq_TH1_Human | 1.58904813 |
39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58511006 |
40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.57594060 |
41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.56103643 |
42 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.54837520 |
43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54522292 |
44 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.51576175 |
45 | * MAF_26560356_Chip-Seq_TH1_Human | 1.51288841 |
46 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47994695 |
47 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.47059978 |
48 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45648612 |
49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44576018 |
50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43979279 |
51 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.43053793 |
52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39347638 |
53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38182535 |
54 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.37871952 |
55 | MYC_22102868_ChIP-Seq_BL_Human | 1.32340062 |
56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29513648 |
57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29372201 |
58 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.28454824 |
59 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.27195528 |
60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25652643 |
61 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.24155957 |
62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22655803 |
63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22511316 |
64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20295980 |
65 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20184377 |
66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20156643 |
67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19958646 |
68 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.19858257 |
69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18416800 |
70 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17423701 |
71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17362628 |
72 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.16923524 |
73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14343488 |
74 | MAF_26560356_Chip-Seq_TH2_Human | 1.13507434 |
75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13009039 |
76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11329636 |
77 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10475837 |
78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08520025 |
79 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.08414605 |
80 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.06981455 |
81 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.06887581 |
82 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.04204308 |
83 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02509884 |
84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02375178 |
85 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.01400097 |
86 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.01016921 |
87 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98888723 |
88 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.97808332 |
89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97789632 |
90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95059188 |
91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93898169 |
92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93831311 |
93 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93661806 |
94 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.93160918 |
95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92955689 |
96 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92558174 |
97 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92277305 |
98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92256736 |
99 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92152389 |
100 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91837396 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000579_abnormal_nail_morphology | 4.84179721 |
2 | MP0003941_abnormal_skin_development | 3.23445507 |
3 | MP0010234_abnormal_vibrissa_follicle | 2.90158074 |
4 | MP0003763_abnormal_thymus_physiology | 2.82144745 |
5 | MP0004381_abnormal_hair_follicle | 2.78563293 |
6 | MP0003693_abnormal_embryo_hatching | 2.62503603 |
7 | MP0001216_abnormal_epidermal_layer | 2.39704876 |
8 | MP0002796_impaired_skin_barrier | 2.32534375 |
9 | MP0005671_abnormal_response_to | 2.30846069 |
10 | MP0006082_CNS_inflammation | 2.25120655 |
11 | MP0002166_altered_tumor_susceptibility | 2.19220063 |
12 | MP0008260_abnormal_autophagy | 2.14919296 |
13 | MP0002254_reproductive_system_inflammat | 2.12059911 |
14 | MP0001835_abnormal_antigen_presentation | 2.03649904 |
15 | MP0003453_abnormal_keratinocyte_physiol | 2.02382622 |
16 | MP0003300_gastrointestinal_ulcer | 1.98103680 |
17 | MP0001800_abnormal_humoral_immune | 1.93899824 |
18 | MP0002006_tumorigenesis | 1.92512848 |
19 | MP0009333_abnormal_splenocyte_physiolog | 1.88615688 |
20 | MP0002060_abnormal_skin_morphology | 1.87704005 |
21 | MP0009785_altered_susceptibility_to | 1.85067674 |
22 | MP0005000_abnormal_immune_tolerance | 1.82009164 |
23 | MP0000685_abnormal_immune_system | 1.81726459 |
24 | MP0004947_skin_inflammation | 1.78902132 |
25 | MP0004957_abnormal_blastocyst_morpholog | 1.78048249 |
26 | MP0010094_abnormal_chromosome_stability | 1.77344974 |
27 | MP0010678_abnormal_skin_adnexa | 1.72071363 |
28 | MP0000467_abnormal_esophagus_morphology | 1.70134397 |
29 | MP0002396_abnormal_hematopoietic_system | 1.69635877 |
30 | MP0002452_abnormal_antigen_presenting | 1.68857118 |
31 | MP0002723_abnormal_immune_serum | 1.68612840 |
32 | MP0003436_decreased_susceptibility_to | 1.65783005 |
33 | MP0002420_abnormal_adaptive_immunity | 1.63919562 |
34 | MP0001819_abnormal_immune_cell | 1.63429780 |
35 | MP0005501_abnormal_skin_physiology | 1.63317659 |
36 | MP0003786_premature_aging | 1.57813920 |
37 | MP0000762_abnormal_tongue_morphology | 1.57477731 |
38 | MP0001873_stomach_inflammation | 1.55248299 |
39 | MP0005025_abnormal_response_to | 1.52628111 |
40 | MP0001790_abnormal_immune_system | 1.50208960 |
41 | MP0005387_immune_system_phenotype | 1.50208960 |
42 | MP0003806_abnormal_nucleotide_metabolis | 1.48365562 |
43 | MP0004264_abnormal_extraembryonic_tissu | 1.47107794 |
44 | MP0003566_abnormal_cell_adhesion | 1.46027722 |
45 | MP0002398_abnormal_bone_marrow | 1.46007999 |
46 | MP0005451_abnormal_body_composition | 1.43994796 |
47 | MP0000377_abnormal_hair_follicle | 1.42237573 |
48 | MP0010155_abnormal_intestine_physiology | 1.41402638 |
49 | MP0000858_altered_metastatic_potential | 1.40401222 |
50 | MP0000703_abnormal_thymus_morphology | 1.38269288 |
51 | MP0002419_abnormal_innate_immunity | 1.38149644 |
52 | MP0003191_abnormal_cellular_cholesterol | 1.37241282 |
53 | MP0008058_abnormal_DNA_repair | 1.37211456 |
54 | MP0000716_abnormal_immune_system | 1.36490127 |
55 | MP0002098_abnormal_vibrissa_morphology | 1.32967617 |
56 | MP0005075_abnormal_melanosome_morpholog | 1.31890922 |
57 | MP0003111_abnormal_nucleus_morphology | 1.31439889 |
58 | MP0000383_abnormal_hair_follicle | 1.30150973 |
59 | MP0002009_preneoplasia | 1.28777716 |
60 | MP0000427_abnormal_hair_cycle | 1.25780739 |
61 | MP0002722_abnormal_immune_system | 1.25777361 |
62 | MP0003724_increased_susceptibility_to | 1.25676887 |
63 | MP0002148_abnormal_hypersensitivity_rea | 1.24430568 |
64 | MP0001849_ear_inflammation | 1.24389451 |
65 | MP0000689_abnormal_spleen_morphology | 1.20179172 |
66 | MP0002405_respiratory_system_inflammati | 1.17671013 |
67 | MP0002429_abnormal_blood_cell | 1.16042813 |
68 | MP0010771_integument_phenotype | 1.15480780 |
69 | MP0005023_abnormal_wound_healing | 1.13683800 |
70 | MP0008007_abnormal_cellular_replicative | 1.12702275 |
71 | MP0002234_abnormal_pharynx_morphology | 1.12220853 |
72 | MP0001845_abnormal_inflammatory_respons | 1.11050649 |
73 | MP0001851_eye_inflammation | 1.10818055 |
74 | MP0010352_gastrointestinal_tract_polyps | 1.09989831 |
75 | MP0002019_abnormal_tumor_incidence | 1.09856828 |
76 | MP0003077_abnormal_cell_cycle | 1.07399413 |
77 | MP0003183_abnormal_peptide_metabolism | 1.06209226 |
78 | MP0009931_abnormal_skin_appearance | 1.04167447 |
79 | MP0000465_gastrointestinal_hemorrhage | 1.02542297 |
80 | MP0001191_abnormal_skin_condition | 1.00446342 |
81 | MP0003315_abnormal_perineum_morphology | 0.97703113 |
82 | MP0000490_abnormal_crypts_of | 0.97393895 |
83 | MP0000678_abnormal_parathyroid_gland | 0.96474420 |
84 | MP0003866_abnormal_defecation | 0.96176609 |
85 | MP0008932_abnormal_embryonic_tissue | 0.95999677 |
86 | MP0001919_abnormal_reproductive_system | 0.95266934 |
87 | MP0005310_abnormal_salivary_gland | 0.92900256 |
88 | MP0002132_abnormal_respiratory_system | 0.92079494 |
89 | MP0002277_abnormal_respiratory_mucosa | 0.91257096 |
90 | MP0001348_abnormal_lacrimal_gland | 0.88354521 |
91 | MP0008877_abnormal_DNA_methylation | 0.87129481 |
92 | MP0003718_maternal_effect | 0.86908586 |
93 | MP0003448_altered_tumor_morphology | 0.85531626 |
94 | MP0000367_abnormal_coat/_hair | 0.83291287 |
95 | MP0008469_abnormal_protein_level | 0.82779944 |
96 | MP0005083_abnormal_biliary_tract | 0.81758468 |
97 | MP0006035_abnormal_mitochondrial_morpho | 0.81427690 |
98 | MP0000350_abnormal_cell_proliferation | 0.81292825 |
99 | MP0005275_abnormal_skin_tensile | 0.79654305 |
100 | MP0005464_abnormal_platelet_physiology | 0.78611364 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Onycholysis (HP:0001806) | 7.17419232 |
2 | Milia (HP:0001056) | 7.02921891 |
3 | Fragile nails (HP:0001808) | 6.57642666 |
4 | Abnormality of nail color (HP:0100643) | 6.51538218 |
5 | Plantar hyperkeratosis (HP:0007556) | 6.44867127 |
6 | Thick nail (HP:0001805) | 4.77272121 |
7 | Oral leukoplakia (HP:0002745) | 4.71505354 |
8 | Alopecia of scalp (HP:0002293) | 4.59743752 |
9 | Palmoplantar hyperkeratosis (HP:0000972) | 4.57062653 |
10 | Palmar hyperkeratosis (HP:0010765) | 4.36623640 |
11 | Amniotic constriction ring (HP:0009775) | 4.20524705 |
12 | Abnormality of placental membranes (HP:0011409) | 4.20524705 |
13 | Nail dystrophy (HP:0008404) | 4.04759949 |
14 | Atrophic scars (HP:0001075) | 3.99366966 |
15 | Ridged nail (HP:0001807) | 3.86927125 |
16 | Abnormal blistering of the skin (HP:0008066) | 3.62802969 |
17 | Pustule (HP:0200039) | 3.54206233 |
18 | Recurrent bacterial skin infections (HP:0005406) | 3.28530573 |
19 | Sparse eyelashes (HP:0000653) | 3.02563258 |
20 | Pili torti (HP:0003777) | 3.01436711 |
21 | Sparse scalp hair (HP:0002209) | 2.96572311 |
22 | Lip pit (HP:0100267) | 2.93245620 |
23 | Dry hair (HP:0011359) | 2.91521153 |
24 | Popliteal pterygium (HP:0009756) | 2.91470045 |
25 | Hypoplasia of dental enamel (HP:0006297) | 2.82288845 |
26 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81461918 |
27 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81461918 |
28 | Cheilitis (HP:0100825) | 2.80080798 |
29 | Autoimmune hemolytic anemia (HP:0001890) | 2.78380738 |
30 | Recurrent fungal infections (HP:0002841) | 2.65824046 |
31 | Abnormality of T cell physiology (HP:0011840) | 2.62893271 |
32 | T lymphocytopenia (HP:0005403) | 2.61967804 |
33 | Ankyloglossia (HP:0010296) | 2.61400495 |
34 | Increased IgE level (HP:0003212) | 2.59707248 |
35 | Right ventricular cardiomyopathy (HP:0011663) | 2.59609004 |
36 | Abnormality of T cells (HP:0002843) | 2.59160181 |
37 | Abnormality of T cell number (HP:0011839) | 2.57444146 |
38 | Increased IgM level (HP:0003496) | 2.54589685 |
39 | Skin ulcer (HP:0200042) | 2.53820940 |
40 | Recurrent skin infections (HP:0001581) | 2.50802668 |
41 | Abnormal hair laboratory examination (HP:0003328) | 2.48508369 |
42 | Recurrent viral infections (HP:0004429) | 2.47808768 |
43 | Recurrent abscess formation (HP:0002722) | 2.39646227 |
44 | Urticaria (HP:0001025) | 2.37802884 |
45 | Selective tooth agenesis (HP:0001592) | 2.36641470 |
46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.35027375 |
47 | Aplasia cutis congenita (HP:0001057) | 2.33526610 |
48 | Premature loss of primary teeth (HP:0006323) | 2.32001178 |
49 | Parakeratosis (HP:0001036) | 2.30444003 |
50 | IgG deficiency (HP:0004315) | 2.26905051 |
51 | Hyperhidrosis (HP:0000975) | 2.25674054 |
52 | Stomatitis (HP:0010280) | 2.25209607 |
53 | Abnormality of oral frenula (HP:0000190) | 2.22796945 |
54 | Aplastic anemia (HP:0001915) | 2.22792992 |
55 | Squamous cell carcinoma (HP:0002860) | 2.20721972 |
56 | Woolly hair (HP:0002224) | 2.20662648 |
57 | Abnormality of the preputium (HP:0100587) | 2.18522554 |
58 | Poikiloderma (HP:0001029) | 2.16052418 |
59 | Hypotrichosis (HP:0001006) | 2.14982301 |
60 | Pterygium (HP:0001059) | 2.12324185 |
61 | Panhypogammaglobulinemia (HP:0003139) | 2.12291562 |
62 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.08208343 |
63 | Carious teeth (HP:0000670) | 2.06985040 |
64 | Inflammation of the large intestine (HP:0002037) | 2.05003423 |
65 | Eczematoid dermatitis (HP:0000976) | 2.02400606 |
66 | Abnormality of the salivary glands (HP:0010286) | 2.01565720 |
67 | Chronic diarrhea (HP:0002028) | 2.01301497 |
68 | Hypoplastic labia majora (HP:0000059) | 1.99790131 |
69 | IgM deficiency (HP:0002850) | 1.99685115 |
70 | Anonychia (HP:0001798) | 1.97854014 |
71 | Death in infancy (HP:0001522) | 1.97745210 |
72 | Gastrointestinal inflammation (HP:0004386) | 1.95668365 |
73 | Periodontitis (HP:0000704) | 1.94901826 |
74 | Lymphoma (HP:0002665) | 1.91809640 |
75 | Abnormality of macrophages (HP:0004311) | 1.89261288 |
76 | Abnormality of the fingernails (HP:0001231) | 1.89155512 |
77 | Erythema (HP:0010783) | 1.87967905 |
78 | Severe combined immunodeficiency (HP:0004430) | 1.87195209 |
79 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87127891 |
80 | Keratoconjunctivitis (HP:0001096) | 1.86124624 |
81 | Ectropion (HP:0000656) | 1.84373293 |
82 | Combined immunodeficiency (HP:0005387) | 1.80243608 |
83 | Abnormality of the labia majora (HP:0012881) | 1.79390040 |
84 | Skin rash (HP:0000988) | 1.79311806 |
85 | Lymphopenia (HP:0001888) | 1.78451599 |
86 | Abnormality of the axillary hair (HP:0100134) | 1.77848916 |
87 | Abnormality of secondary sexual hair (HP:0009888) | 1.77848916 |
88 | Flat occiput (HP:0005469) | 1.76555341 |
89 | Multifactorial inheritance (HP:0001426) | 1.75118281 |
90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.73546949 |
91 | Palmoplantar keratoderma (HP:0000982) | 1.73401763 |
92 | Verrucae (HP:0200043) | 1.72276041 |
93 | Papilloma (HP:0012740) | 1.72276041 |
94 | IgA deficiency (HP:0002720) | 1.72169330 |
95 | Agammaglobulinemia (HP:0004432) | 1.69317731 |
96 | Abnormality of the neuromuscular junction (HP:0003398) | 1.66454860 |
97 | Fatigable weakness (HP:0003473) | 1.66454860 |
98 | Chromsome breakage (HP:0040012) | 1.66402037 |
99 | Abnormality of B cell number (HP:0010975) | 1.65812072 |
100 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.64959538 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST4 | 3.43213832 |
2 | BUB1 | 2.88161705 |
3 | MAP3K13 | 2.82181715 |
4 | MAP3K2 | 2.60139567 |
5 | PASK | 2.48364131 |
6 | FGR | 2.38866924 |
7 | EIF2AK1 | 2.37223071 |
8 | STK24 | 2.27155537 |
9 | TLK1 | 2.14958120 |
10 | MAP3K14 | 2.05139552 |
11 | STK10 | 2.01140025 |
12 | MAP4K1 | 1.99988108 |
13 | MST1R | 1.99614487 |
14 | ZAK | 1.98216696 |
15 | MET | 1.97094745 |
16 | ITK | 1.84643147 |
17 | GRK6 | 1.78288376 |
18 | JAK3 | 1.68469917 |
19 | EIF2AK3 | 1.58008207 |
20 | PIM2 | 1.54694731 |
21 | CSK | 1.52632017 |
22 | MAP3K3 | 1.45598065 |
23 | NUAK1 | 1.45269166 |
24 | ARAF | 1.44662256 |
25 | BLK | 1.40079790 |
26 | CSF1R | 1.37195458 |
27 | JAK1 | 1.34800598 |
28 | SMG1 | 1.34111976 |
29 | TYK2 | 1.32735948 |
30 | TXK | 1.32143754 |
31 | IRAK4 | 1.31502362 |
32 | TESK2 | 1.30496114 |
33 | IKBKB | 1.26340926 |
34 | NME2 | 1.26248554 |
35 | FES | 1.22157517 |
36 | TAF1 | 1.19924870 |
37 | LATS1 | 1.16577835 |
38 | NLK | 1.16437167 |
39 | RIPK4 | 1.14723426 |
40 | BRSK2 | 1.14242181 |
41 | TGFBR2 | 1.11748771 |
42 | BTK | 1.10074613 |
43 | TTK | 1.08860049 |
44 | SCYL2 | 1.08244959 |
45 | PAK4 | 1.06720875 |
46 | ERN1 | 1.02362816 |
47 | SRPK1 | 0.99774806 |
48 | EPHA2 | 0.96264918 |
49 | SYK | 0.94973748 |
50 | EPHB1 | 0.94576211 |
51 | PBK | 0.94057573 |
52 | RAF1 | 0.91909203 |
53 | STK16 | 0.89582696 |
54 | EIF2AK2 | 0.88475896 |
55 | IKBKE | 0.88440088 |
56 | PIM1 | 0.88298428 |
57 | MAP3K9 | 0.88273372 |
58 | ZAP70 | 0.86631581 |
59 | TSSK6 | 0.86195948 |
60 | NME1 | 0.84056865 |
61 | BMPR2 | 0.81770982 |
62 | CDK4 | 0.78586890 |
63 | TBK1 | 0.78355867 |
64 | LYN | 0.78013298 |
65 | STK3 | 0.77211911 |
66 | PLK4 | 0.76777251 |
67 | HCK | 0.76747165 |
68 | STK38L | 0.75133877 |
69 | VRK2 | 0.73205338 |
70 | TRIM28 | 0.72242795 |
71 | KSR2 | 0.70751695 |
72 | RPS6KB2 | 0.67337049 |
73 | LCK | 0.67238558 |
74 | VRK1 | 0.67220726 |
75 | TAOK3 | 0.67097237 |
76 | BRD4 | 0.66328712 |
77 | TEC | 0.64068590 |
78 | MAP3K1 | 0.63987853 |
79 | MAP3K8 | 0.60648536 |
80 | FLT3 | 0.59588287 |
81 | NEK9 | 0.59501446 |
82 | PTK2B | 0.59395289 |
83 | JAK2 | 0.55863031 |
84 | SIK3 | 0.55794132 |
85 | MAP2K3 | 0.55750531 |
86 | CDC7 | 0.55517185 |
87 | MAP3K10 | 0.53788817 |
88 | MAP3K12 | 0.53690619 |
89 | CDK6 | 0.48401260 |
90 | RPS6KA4 | 0.47927814 |
91 | TRPM7 | 0.47759157 |
92 | PLK1 | 0.47475136 |
93 | PRKCI | 0.47215984 |
94 | GRK7 | 0.43232247 |
95 | ERBB3 | 0.41897770 |
96 | BRAF | 0.41703883 |
97 | TNK2 | 0.39839967 |
98 | BRSK1 | 0.38471522 |
99 | MAP2K2 | 0.36396590 |
100 | AURKA | 0.35926133 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.25382158 |
2 | Proteasome_Homo sapiens_hsa03050 | 3.19776348 |
3 | DNA replication_Homo sapiens_hsa03030 | 2.50617774 |
4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.47887362 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 2.31785696 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.05247774 |
7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.04706565 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.01425807 |
9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.96576691 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91228839 |
11 | Measles_Homo sapiens_hsa05162 | 1.90040637 |
12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.89752675 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85991087 |
14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.85591033 |
15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.80928466 |
16 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.80081648 |
17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71922966 |
18 | Homologous recombination_Homo sapiens_hsa03440 | 1.69881760 |
19 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.69509581 |
20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65684708 |
21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64367697 |
22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.58608934 |
23 | Cell cycle_Homo sapiens_hsa04110 | 1.56367811 |
24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55798046 |
25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.54198212 |
26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50661544 |
27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.50519715 |
28 | Base excision repair_Homo sapiens_hsa03410 | 1.47455639 |
29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46625047 |
30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.37614175 |
31 | RNA polymerase_Homo sapiens_hsa03020 | 1.37354906 |
32 | Shigellosis_Homo sapiens_hsa05131 | 1.35045546 |
33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34406435 |
34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33123474 |
35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32719704 |
36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32654068 |
37 | RNA transport_Homo sapiens_hsa03013 | 1.27249312 |
38 | Asthma_Homo sapiens_hsa05310 | 1.23577974 |
39 | Influenza A_Homo sapiens_hsa05164 | 1.20893115 |
40 | Legionellosis_Homo sapiens_hsa05134 | 1.20808884 |
41 | RNA degradation_Homo sapiens_hsa03018 | 1.20470395 |
42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19823317 |
43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.15539503 |
44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13971690 |
45 | Tuberculosis_Homo sapiens_hsa05152 | 1.12934073 |
46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.12628798 |
47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06516475 |
48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06155426 |
49 | Apoptosis_Homo sapiens_hsa04210 | 1.04539236 |
50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.01913033 |
51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01092132 |
52 | Spliceosome_Homo sapiens_hsa03040 | 0.99335223 |
53 | Ribosome_Homo sapiens_hsa03010 | 0.96944334 |
54 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96726961 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 0.95514110 |
56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92245011 |
57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90348157 |
58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90102705 |
59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87399972 |
60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86424160 |
61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.84209699 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82346567 |
63 | Hepatitis C_Homo sapiens_hsa05160 | 0.80953643 |
64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77622024 |
65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77178119 |
66 | Malaria_Homo sapiens_hsa05144 | 0.77142408 |
67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76048483 |
68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75069934 |
69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69833928 |
70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69710488 |
71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69465222 |
72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65180989 |
73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64933884 |
74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63636910 |
75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61239958 |
76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57021522 |
77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55207293 |
78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52625625 |
79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51234097 |
80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50671324 |
81 | Protein export_Homo sapiens_hsa03060 | 0.46278450 |
82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44001769 |
83 | Prostate cancer_Homo sapiens_hsa05215 | 0.43076917 |
84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42212986 |
85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.41344321 |
86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40841583 |
87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39376726 |
88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38920589 |
89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38138324 |
90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37453896 |
91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36295287 |
92 | Salmonella infection_Homo sapiens_hsa05132 | 0.35778110 |
93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34098631 |
94 | Endocytosis_Homo sapiens_hsa04144 | 0.33060519 |
95 | Bladder cancer_Homo sapiens_hsa05219 | 0.32773285 |
96 | Purine metabolism_Homo sapiens_hsa00230 | 0.31638704 |
97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31623015 |
98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30221076 |
99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29761385 |
100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28778249 |